Correlation between Prognostic Nutritional Index, Glasgow Prognostic Score, Systemic Inflammatory Response, and TNM Staging in Colorectal Cancer Patients

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Printz C. Death rates for colorectal cancer rising for individuals aged younger than 55 years. Cancer. 2018;124(2):229.
   PubMed Web of Science ®Google Scholar
• Gu XB, Tian T, Tian XJ, Zhang XJ. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis. Sci Rep. 2015;5(1):12493.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z. Prognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma. Onco Targets Ther. 2016;9:6417–6423.
   PubMed Web of Science ®Google Scholar
• Roncolato FT, Berton-Rigaud D, O’Connell R, Lanceley A, Sehouli J, Buizen L, Okamoto A, Aotani E, Lorusso D, Donnellan P, et al. Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS). Gynecol Oncol. 2018;148(1):36–41.
   PubMed Web of Science ®Google Scholar
• Shibutani M, Maeda K, Nagahara H, Ohtani H, Iseki Y, Ikeya T, Sugano K, Hirakawa K. The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer. World J Surg Oncol. 2015;13(1):194.
   PubMed Web of Science ®Google Scholar
• Zeng X, Tao H. Diagnostic and prognostic serum marker of cholangiocarcinoma (review). Oncol Lett. 2015;9(1):3–8.
   PubMed Web of Science ®Google Scholar
• Song S, Li C, Li S, Gao H, Lan X, Xue Y. Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer. Onco Targets Ther. 2017;10:3145–3154.
   PubMed Web of Science ®Google Scholar
• Greene FL. Current TNM staging of colorectal cancer. Lancet Oncol. 2007;8(7):572–573.
   PubMed Web of Science ®Google Scholar
• Proctor MJ, Talwar D, Balmar SM, O’Reilly DSJ, Foulis AK, Horgan PG, Morrison DS, McMillan DC. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer. 2010;103(6):870–876.
   PubMed Web of Science ®Google Scholar
• Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–1005.
   PubMedGoogle Scholar
• Hong S, Zhou T, Fang W, Xue C, Hu Z, Qin T, Tang Y, Chen Y, Ma Y, Yang Y, et al. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients. Tumor Biol. 2015;36(5):3389–3397.
   PubMedGoogle Scholar
• Haraga J, Nakamura K, Omichi C, Nishida T, Haruma T, Kusumoto T, Seki N, Masuyama H, Katayama N, Kanazawa S, et al. Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy. Mol Clin Oncol. 2016;5(5):567–574.
   PubMed Web of Science ®Google Scholar
• Mohri T, Mohri Y, Shigemori T, Takeuchi K, Itoh Y, Kato T. Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer. World J Surg Oncol. 2016;14(1):170.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–193.
   PubMed Web of Science ®Google Scholar
• Jian-Hui C, Iskandar EA, Cai S-I, Chen C-Q, Wu H, Xu J-B, He Y-L. Significance of Onodera’s prognostic nutritional index in patients with colorectal cancer: a large cohort study in a single Chinese institution. Tumor Biol. 2016;37(3):3277–3283.
   PubMedGoogle Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Iseki Y, Shibutani M, Maeda K, Nagahara H, Tamura T, Ohira G, Yamazoe S, Kimura K, Toyokawa T, Amano R, et al. The impact of the preoperative peripheral lymphocyte count and lymphocyte percentage in patients with colorectal cancer. Surg Today. 2017;47(6):743–754.
   PubMed Web of Science ®Google Scholar
• Liang L, Zhu J, Jia H, Huang L, Li D, Li Q, Li X. Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy. Oncotarget. 2016;7(1):1014–1028.
   PubMedGoogle Scholar
• Fan H, Shao Z-Y, Xiao Y-Y, Xie Z-H, Chen W, Xie H, Qin G-Y, Zhao N-Q. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer. J Cancer Res Clin Oncol. 2016;142(6):1285–1297.
   PubMed Web of Science ®Google Scholar
• Fearon KC, Barber MD, Falconer JS, McMillan DC, Ross JA, Preston T. Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg. 1999;23(6):584–588.
   PubMed Web of Science ®Google Scholar
• McMillan DC, Watson WS, O’Gorman P, Preston T, Scott HR, McArdle CS. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer. 2001;39(2):210–213.
   PubMed Web of Science ®Google Scholar